Growing millimeter‐scaled functional tissue remains a major challenge in the field of tissue engineering. Therefore, microporous annealed particles (MAPs) are emerging as promising porous biomaterials that are formed by assembly of microgel building blocks. To further vary the pore size and increase overall MAP porosity of mechanically stable scaffolds, rod‐shaped microgels with high aspect ratios up to 20 are chemically interlinked into highly porous scaffolds. Polyethylene glycol based microgels (width 10 µm, lengths up to 200 µm) are produced via in‐mold polymerization and covalently interlinked into stable 3D scaffolds via epoxy‐amine chemistry. For the first time, MAP porosities can be enhanced by increasing the microgel aspect ratio (mean pore sizes ranging from 39 to 82 µm, porosities from 65 to 90%). These porosities are significantly higher compared to constructs made from spherical or lower aspect ratio rod‐shaped microgels. Rapid filling of the pores by either murine or primary human fibroblasts is ensured as cells migrate and grow extensively into these scaffolds. Overall, this study demonstrates that highly porous, stable macroporous hydrogels can be achieved with a very low partial volume of synthetic, high aspect ratio microgels, leading to large empty volumes available for cell ingrowth and cell–cell interactions.
The chemical industry can now seize the opportunity to improve the sustainability of its processes by replacing fossil carbon sources with renewable alternatives such as CO2, biomass, and plastics, thereby thinking ahead and having a look into the future. For their conversion to intermediate and final products, different types of catalysts-microbial, enzymatic, and organometallic-can be applied. The first part of this review shows how these catalysts can work separately in parallel, each route with unique requirements and advantages. While the different types of catalysts are often seen as competitive approaches, an increasing number of examples highlight, how combinations and concatenations of catalysts of the complete spectrum can open new roads to new products. Therefore, the second part focuses on the different catalysts either in one-step, one-pot transformations or in reaction cascades. In the former, the reaction conditions must be conflated but purification steps are minimized. In the latter, each catalyst can work under optimal conditions and the "hand-over points" should be chosen according to defined criteria like minimal energy usage during separation procedures. The examples are discussed in the context of the contributions of catalysis to the envisaged (bio)economy.
Metaraminol is a chiral amino alcohol and plays an important role as a precursor molecule and active pharmaceutical ingredient in industry. Its enzymatic synthesis has been developed in recent years and can serve as an alternative to conventional synthesis routes that use toxic, fossil‐based resources. Although the enzymatic two‐step reaction toward metaraminol has been intensively investigated in the past, full conversion has never been reached in the amine transaminase‐catalyzed step. In this study, we focus on identifying and overcoming the hurdles of the transamination step to reach higher metaraminol yields. Photometric and LC‐MS analyses revealed side‐product formation as a major drawback for the enzymatic metaraminol synthesis. Besides the oxidation of ( R )‐3‐OH‐PAC as well as its imine formation with isopropylamine, we demonstrate for the first time the adduct formation of the cofactor pyridoxal‐5’‐phosphate with metaraminol. Only by changing the amine transaminase formulation to purified enzyme and increasing the concentration by tenfold, >99% product yield with a metaraminol concentration of 75 mM was reached. Further, we successfully integrated the amine donor l‐alanine by applying a continuous product extraction system as an alternative to isopropylamine. We believe that our findings and optimization strategies can also serve as a blueprint for other amine‐based syntheses.